Press Releases August 6, 2026 08:47 AM

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

Milestone Scientific Announces Q2 2026 Financial Results Conference Call Scheduled for August 14

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
MLSS

Milestone Scientific Inc., a developer of computerized drug delivery instruments, will host a conference call on August 14, 2026, to discuss its financial results for the second quarter ended June 30, 2026. The call will also cover corporate progress and developments. Milestone specializes in technology-driven medical and dental injection devices aimed at improving precision and patient comfort.

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
MLSS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Milestone Scientific will report Q2 2026 financial results on August 14, 2026.
  • Company develops innovative computer-controlled injection technology using proprietary Dynamic Pressure Sensing Technology®.
  • The financial update and corporate progress could provide insight into the company's performance and developments in medical and dental technology sectors.

ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company’s financial results for the second quarter ended June 30, 2026, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 252290. A live webcast and replay are available here: https://www.webcaster5.com/Webcast/Page/2306/54387.

An audio replay of the call will be available through August 28, 2026, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 54387.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact:

HAYDEN IR:
James Carbonara
(646)-755-7412
james@haydenir.com

Brett Maas
(646) 536-7331
brett@haydenir.com


Risks

  • Financial results may show volatility or underperformance impacting market perception.
  • Dependence on successful adoption and commercialization of proprietary technology in a competitive medical devices market.
  • Potential regulatory or product development risks affecting pipeline and future revenues.

More from Press Releases

Eastern International Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Sep 11, 2026 ArrowMark Financial Corp. Announces Q2 Results and Special Distribution of $0.10 and Monthly Cash Distribution of $0.15 per Share for September 2026 Sep 11, 2026 Rainier Acquisition Corporation Announces Separation of Its Class A Ordinary Shares and Warrants on Nasdaq, Commencing September 14, 2026 Sep 11, 2026 Arteris Announces New Employment Inducement Grants Sep 11, 2026 Standard Lithium Announces Change to Board of Directors Sep 11, 2026